InsidersTradesSigma
Follow the 큐라티스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 큐라티스 has recorded 8 insider filings. Market capitalisation: €42.2bn. The latest transaction was filed on 6 April 2026 (Other). Among the most active insiders: 인벤티지랩. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations
큐라티스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions to enhance healthcare.